Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Diabetes & Endocrinology
Activation of inflammasomes in type 2 diabetes (metabolic stress... | Download Scientific Diagram
The Surprising Story of IL-2 - The American Journal of Pathology
Interleukin-2 (IL-2): Why Does This Cytokine Have Immunostimulatory and Immunoregulatory Functions?
![PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bbdf7240373d1a2a33a93571f5119ff3b51e311/5-Figure4-1.png "PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar")
PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology
The role of interleukin-2 during homeostasis and activation of the immune system | Nature Reviews Immunology
Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus
Frontiers | The role of interleukin-1β in type 2 diabetes mellitus: A systematic review and meta-analysis
![PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bbdf7240373d1a2a33a93571f5119ff3b51e311/2-Figure1-1.png "PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar")
PDF] Central Role for Interleukin-2 in Type 1 Diabetes | Semantic Scholar
Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis | SpringerLink
Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes | Nature Communications
Level of interleukin-2 in four groups: Group 1-patients with diabetes... | Download Scientific Diagram
Possible Role of Interleukin-1β in Type 2 Diabetes Onset and Implications for Anti-inflammatory Therapy Strategies | PLOS Computational Biology
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases | Nature Reviews Immunology
Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets - Lu - 2020 - Clinical & Translational Immunology - Wiley Online Library
Article: Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases (full text) - September 2020 - NJM
Designer-Molekül gegen Typ-2-Diabetes: ärztliches journal
Acquired Defect in Interleukin-2 Production in Patients with Type I Diabetes Mellitus | NEJM
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology
The role of interleukin-2 during homeostasis and activation of the immune system | Nature Reviews Immunology
Acquired Defect in Interleukin-2 Production in Patients with Type I Diabetes Mellitus | NEJM
